Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry

Meningitis Vaccination Advances

March 2008 | Industry News

There has been significant progress on a low cost vaccination against Neisseria meningitidis, one of two strains of bacteria that cause the majority of Africa's meningitis caseload. Phase III clinical trials conducted in the Gambia, Senegal and Mali have shown positive results, and it is expected that the vaccine can be introduced from

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries